2017, Feb. 22-23: VEROVACCiNES selected as Emerging Company at ANIMAL HEALTH INVESTMENT Europe, London UK conference 2017.

The selection committee of the conference ANIMAL HEALTH INVESTMENT Europe, London UK, selected the startup project VEROVACCiNES as one of 12 presenting emerging companies. VEROVACCiNES is the only “yet to be founded” participant.
This conference is dedicated to showcasing to investors the most innovative emerging animal health companies covering the companion, aquaculture and production animal space.